Emergent Biosolutions, Inc. (EBS) Financials
EBS Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2024-03-31 | 1.8 billion | 1.1 billion |
2023-12-31 | 1.8 billion | 1.2 billion |
2023-09-30 | 1.9 billion | 1.2 billion |
2023-06-30 | 2.2 billion | 1.2 billion |
EBS Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2024-03-31 | -73.4 million | 5.9 million |
2023-12-31 | 20.7 million | 4.0 million |
2023-09-30 | 47.4 million | 4.0 million |
2023-06-30 | -126.9 million | 8.3 million |
EBS Net Income
Graph available only for supporters. Become a supporter to see it.
Date | Net Income |
---|---|
2024-03-31 | 9.0 million |
2023-12-31 | -49.5 million |
2023-09-30 | -263.4 million |
2023-06-30 | -261.3 million |
EBS Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2024-03-31 | 78.5 million | - | - |
2023-12-31 | 111.7 million | - | - |
2023-09-30 | 87.8 million | - | - |
2023-06-30 | 88.6 million | 448.0 million | - |
EBS Shares Outstanding
EBS Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2024-03-31 | 10.8 million | 15.1 million | - | - |
2023-12-31 | 11.4 million | 29.2 million | 89.7 million | - |
2023-09-30 | 12.6 million | 15.3 million | 86.0 million | - |
2023-06-30 | 12.5 million | 26.0 million | 91.4 million | - |
EBS Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2024-03-31 | 300.4 million | 159.5 million |
2023-12-31 | 276.6 million | 201.8 million |
2023-09-30 | 270.5 million | 176.8 million |
2023-06-30 | 337.9 million | 190.6 million |
EBS
Price: $3.89
52 week price:
Earnings Per Share: -14.85 USD
P/E Ratio: -0.10
Exchange: NYQ
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 633400
Ebitda: 58.1 millionMarket Capitalization: 172.9 million